研究論文（112.01～112.12)
| 篇序 |
作者 |
論文題目 | 發表雜誌名稱 (含年月/卷期/頁次) |
屬性 (SCI、SSCI、IEEE) |
|---|---|---|---|---|
| 1 | 許銘仁(1) | Glucosinolates Extracts from Brassica juncea Ameliorate HFD-Induced Non-Alcoholic Steatohepatitis | Nutrients 2023,15(16),3497 | SCI |
| 2 | 古關光浩(1)、許銘仁(1) | Eradication therapy may decrease the risk of immune thrombocytopenia after Helicobacter pylori infection: a retrospective cohort study in Taiwan | BMC Gastroenterology 2023 Vol. 23 Issue 1 Pages 36 | SCI |
| 3 | 郭行道(2) | Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan | Journal of hepatology. 2023, 78, 281–292 | SCI |
| 4 | 郭行道(3) | Efectiveness and safety of 8 week glecaprevir/pibrentasvir in HCV treatment naïve patients with compensated cirrhosis: real world experience from Taiwan nationwide HCV registry | Hepatology International (2023) 17:550–561 | SCI |
| 5 |
馮意哲(1) |
Interdependence of glycemic and lipid modulation in cured chronic hepatitis Cpatients by direct-acting antiviral agents | Journal of Microbiology, Immunology and Infection56(2023)20-30 | SCI |
| 6 |
馮意哲(3) |
Reversibility of some oxidative stress markers in chronic hepatitis C patients after receiving direct-acting antiviral agents | Journal of Virus Eradication 2023 Feb 26;9(1):100318 | SCI |
| 7 | 馮意哲(5) | Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study | Inflammatory Bowel Disease, 2023 Nov 2;29(11):1730-1740 | SCI |
| 8 | 王品貽(1)、王宿鴻(C)、許銘仁(3) | Lymphocyte-Rich Hepatocellular Carcinoma with Multiple Lymphadenopathy and Positive Epstein–Barr Virus Encoding Region | Case Reports in Hepatology 2023:1-5 | SCI |
| 9 | 楊畯棋 (C) | Acute kidney injury in patients with COVID-19 compared to those with influenza: a systematic review and meta-analysis | Front. Med. 10:1252990.2023 | SCI |
| 10 | 陳季杏(C) | Clinical effectiveness of nirmatrevir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis | Expert review of anti-infective therapy/2023/ | SCI |
| 11 | 吳佩叡(1)、郭行道(C)、許銘仁(C) | The mortality of hospitalized patients with COVID-19 and non-cirrhotic chronic liver disease: A retrospective multi-center study | PeerJ/2022/11:e16582 | SCI |